Dubai-based Vector Pharma FZCO has signed an exclusive agreement with R-Pharm US (Princeton, New Jersey) related to distributing the drug Ixempra (ixabepilone) in the Middle East and North Africa. The chemotherapy agent Ixempra can be used as a monotherapy or in combination with capecitabine to treat metastatic or locally advanced breast cancer. The drug is…